The future role of AI models in hematology and the need for high-quality data sets

Thomas Coats, PhD, Royal Devon University Hospital Foundation Trust, Exeter, UK, discusses the future of artificial intelligence (AI) models in the field of hematology. Using AI models in image recognition will allow for improved efficiency and detection of high-risk areas within a sample. For AI models to be used for treatment selection and the accurate prediction of clinical outcomes and toxicities, Dr Coats highlights that high-quality, robust data sets must be collated. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.